Articles

Is anyone paying attention?

John Paulson, the investor who successfully bet against the subprime-mortgage bubble, said he would withdraw his money from the market if Vice President Kamala Harris wins in November.

Merck & Co. Inc. said Wednesday the U.S. Food and Drug Administration has approved its blockbuster cancer drug Keytruda as a treatment for malignant plural mesothelioma, a rare cancer associated with asbestos.

Oil futures fell Wednesday, feeling pressure after industry data showed a rise in U.S. crude and product inventories as investors awaited an expected Federal Reserve rate cut.

The directors said the decision comes after months of work that failed to result in an actionable plan that meets the interests of non-affiliated shareholders.

The Fed’s interest-rate cuts will soften the prices consumers pay for debt — but people may not see an impact on their payments for a while.

Mortgage applications rose 14.2% in the last week, the Mortgage Bankers Association said.

Shares of Intuitive Machines Inc. are skyrocketing Wednesday, lifted by the award of a NASA contract that could be worth up to $4.82 billion. 

It may be a puzzle as to why the Fed is cutting at all when the economy is far from recession. One indicator suggests an answer.

The equal-weight S&P 500 has beaten its more popular sibling in the race back to record highs. That tells us a lot about how U.S. stock-market leadership has shifted since the start of the third quarter.

Home buyers and sellers could come off the sidelines after the Fed’s first interest-rate cut since 2020.

JPMorgan Chase is in negotiations to take over Apple’s credit card venture from Goldman Sachs after the tech frim made a push to cut its ties with the New York bank last year